curacleltd Past Earnings Performance
Past criteria checks 0/6
curacleltd has been growing earnings at an average annual rate of 16.8%, while the Biotechs industry saw earnings growing at 1.6% annually. Revenues have been growing at an average rate of 16.4% per year.
Key information
16.8%
Earnings growth rate
40.1%
EPS growth rate
| Biotechs Industry Growth | 11.7% |
| Revenue growth rate | 16.4% |
| Return on equity | -44.1% |
| Net Margin | -391.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How curacleltd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4,038 | -15,819 | 17,729 | 0 |
| 31 Mar 24 | 5,799 | -14,418 | 18,664 | 0 |
| 31 Dec 23 | 10,294 | -11,586 | 19,841 | 0 |
| 30 Sep 23 | 10,061 | -10,598 | 19,496 | 0 |
| 30 Jun 23 | 8,668 | -8,482 | 16,909 | -315 |
| 31 Mar 23 | 7,928 | -9,511 | 16,731 | -234 |
| 31 Dec 22 | 3,583 | -11,406 | 14,658 | 0 |
| 30 Sep 22 | 8,799 | -4,621 | 17,781 | -4,075 |
| 30 Jun 22 | 7,926 | -6,977 | 14,498 | 447 |
| 31 Mar 22 | 6,905 | -6,219 | 12,468 | 740 |
| 31 Dec 21 | 6,255 | -6,678 | 12,080 | 607 |
| 30 Sep 21 | 0 | -18,904 | 9,858 | 374 |
| 31 Mar 21 | 0 | -27,890 | 8,559 | -940 |
| 31 Dec 20 | 0 | -28,610 | 7,031 | 479 |
| 31 Dec 19 | 0 | -13,989 | 1,425 | 4,218 |
Quality Earnings: A365270 is currently unprofitable.
Growing Profit Margin: A365270 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A365270 is unprofitable, but has reduced losses over the past 5 years at a rate of 16.8% per year.
Accelerating Growth: Unable to compare A365270's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A365270 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-1.3%).
Return on Equity
High ROE: A365270 has a negative Return on Equity (-44.15%), as it is currently unprofitable.